operation during 2019 Agenda 3: To Consider and approve the statement of financial position and income statement for the year-end period of 31 December 2019, and audited report. 3 Agenda 4: To consider and

wheat used in Q1’2020 cheaper than in Q1’2019 due to wheat prices that have been purchased since the middle of the year together with the strengthening baht at the end of last year. The average capacity

payment based on the company’s group operating results and a decrease in unbilled construction value as the company’s group gradually collected money from most of the projects that were delivered at the end

Analysis have been submitted based on separate financial statements only.) Summary overview From the end of 1st quarter of 2020, the epidemic situation of the coronavirus disease 2019 (COVID-19) has

46.7% to 47.7%. According to the Company has efficiently managed portion of sales for each product group. In addition, at the end of 2nd quarter and during 3rd quarter, the Baht appreciation which affect

Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as

metal packaging industry. After some of new products sample had been introduced to customers for testing, we start to receive orders from Thailand customers in the end of 3rd quarter. Our plan is to

the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling price per unit (e.g. NAV or NAV+front-end fee) 1.5 Financial statement (if applicable) 1.6 Fund manager and major

price per unit (e.g. NAV or NAV+front-end fee) 1.5 Financial statement (if applicable) 1.6 Fund manager and major unitholders of the CIS (if applicable) 1.7 Auditor 1.8 Procedures for offering of the CIS

/ policy 1.2 Capital of the CIS 1.3 Amount and details of units of the CIS offered for sale 1.4 Expected selling price per unit (e.g. NAV or NAV+front-end fee) 1.5 Financial statement (if applicable) 1.6